Manila Bulletin
Processing of documents delays Pfizer vaccines delivery in PH - Dizon
The arrival of 117,000 doses of Pfizer-BioNTech COVID-19 vaccine, intended for the Philippines through the COVAX facility, has been postponed due to processing delays in documentation with COVAX and the WHO.
Presidential spokesperson Harry Roque Jr. had previously announced that these Pfizer-BioNTech vaccines were expected to arrive by mid-February, with mass vaccination possibly starting on February 15.
Healthcare workers in COVID-19 referral hospitals in Metro Manila, Cebu, and Davao are prioritized to receive the Pfizer-BioNTech vaccines due to the specialized storage requirements of -70 to -80 degrees Celsius.
In addition to the Pfizer vaccines, 600,000 doses of Sinovac vaccines, donated by the Chinese government, are scheduled to arrive on February 23, although they are still awaiting emergency use authorization from the FDA.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines will not lose its 44 million vaccine allocation from the COVAX facility despite a one-week delay in the delivery of Pfizer vaccines.
Read more →
The Department of Health (DOH) and government agencies conducted a simulation exercise for the arrival and distribution of COVID-19 vaccines, including processes from arrival at the airport to storage.
Read more →
The Philippine government has signed indemnification agreements, a requirement for the COVAX global facility, allowing for the delivery of COVID-19 vaccines.
Read more →
The Philippine government is reviewing its indemnification agreement with Pfizer-BioNTech to ensure compensation for individuals experiencing serious side effects from the COVID-19 vaccine.
Read more →
The Philippines is set to receive up to 10 million doses of COVID-19 vaccines in the first quarter of 2021, with most being the AstraZeneca brand, according to British Ambassador Daniel Pruce.
Read more →